We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$216M
2
CPT icon
Camden Property Trust
CPT
+$180M
3
AMT icon
American Tower
AMT
+$137M
4
PLD icon
Prologis
PLD
+$122M
5
EXR icon
Extra Space Storage
EXR
+$90.4M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$181M
2
AVB icon
AvalonBay Communities
AVB
+$166M
3
HST icon
Host Hotels & Resorts
HST
+$163M
4
REG icon
Regency Centers
REG
+$134M
5
ESS icon
Essex Property Trust
ESS
+$92.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPH icon
1126
Amphastar Pharmaceuticals
AMPH
$907M
$6K ﹤0.01%
165
– –
IRWD icon
1127
Ironwood Pharmaceuticals
IRWD
$586M
$6K ﹤0.01%
478
– –
KYMR icon
1128
Kymera Therapeutics
KYMR
$8.66B
$6K ﹤0.01%
150
– –
LGND icon
1129
Ligand Pharmaceuticals
LGND
$5.77B
$6K ﹤0.01%
79
– –
MDGL icon
1130
Madrigal Pharmaceuticals
MDGL
$12.6B
$6K ﹤0.01%
57
– –
PACB icon
1131
Pacific Biosciences
PACB
$435M
$6K ﹤0.01%
682
– –
PRTA icon
1132
Prothena Corp
PRTA
$448M
$6K ﹤0.01%
154
– –
SAGE
1133
DELISTED
Sage Therapeutics
SAGE
$6K ﹤0.01%
172
– –
SUPN icon
1134
Supernus Pharmaceuticals
SUPN
$2.7B
$6K ﹤0.01%
182
– –
VCYT icon
1135
Veracyte
VCYT
$4.45B
$6K ﹤0.01%
207
– –
ZNTL icon
1136
Zentalis Pharmaceuticals
ZNTL
$332M
$6K ﹤0.01%
132
– –
ISEE
1137
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$6K ﹤0.01%
356
– –
AGIO icon
1138
Agios Pharmaceuticals
AGIO
$2.08B
$5K ﹤0.01%
158
– –
AUPH icon
1139
Aurinia Pharmaceuticals
AUPH
$1.95B
$5K ﹤0.01%
378
– –
AXSM icon
1140
Axsome Therapeutics
AXSM
$11.7B
$5K ﹤0.01%
129
– –
ENTA icon
1141
Enanta Pharmaceuticals
ENTA
$362M
$5K ﹤0.01%
69
– –
GMAB icon
1142
Genmab
GMAB
$17.5B
$5K ﹤0.01%
137
– –
GRFS
1143
Grifois
GRFS
$5.55B
$5K ﹤0.01%
398
– –
KRYS icon
1144
Krystal Biotech
KRYS
$10.7B
$5K ﹤0.01%
76
– –
RGNX icon
1145
Regenxbio
RGNX
$616M
$5K ﹤0.01%
146
– –
RVMD icon
1146
Revolution Medicines
RVMD
$38.5B
$5K ﹤0.01%
215
– –
SANA icon
1147
Sana Biotechnology
SANA
$882M
$5K ﹤0.01%
551
– –
TVTX icon
1148
Travere Therapeutics
TVTX
$5.17B
$5K ﹤0.01%
208
– –
XNCR icon
1149
Xencor
XNCR
$1.45B
$5K ﹤0.01%
171
– –
RVNC
1150
DELISTED
Revance Therapeutics, Inc.
RVNC
$5K ﹤0.01%
246
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.